What is your FDA regulatory strategy and what is the timeline to clearance?

This is a critical due diligence question for HealthTech startups. DDR automatically surfaces answers to this and 3 other key questions by analyzing the pitch deck and running OSINT research across 13 data sources.

How do you think about reimbursement — are you currently covered or seeking a CPT code?

This is a critical due diligence question for HealthTech startups. DDR automatically surfaces answers to this and 3 other key questions by analyzing the pitch deck and running OSINT research across 13 data sources.

Can you share your clinical outcomes data with methodology?

This is a critical due diligence question for HealthTech startups. DDR automatically surfaces answers to this and 3 other key questions by analyzing the pitch deck and running OSINT research across 13 data sources.

Who are the 3 health systems you're currently selling to and what does the sales cycle look like?

This is a critical due diligence question for HealthTech startups. DDR automatically surfaces answers to this and 3 other key questions by analyzing the pitch deck and running OSINT research across 13 data sources.

Due Diligence Guides › HealthTech › Growth / Pre-IPO

HealthTech Startup Due Diligence at Growth / Pre-IPO Stage: Complete Investor Guide

Technology platforms improving healthcare delivery, patient outcomes, clinical operations, and health data — including digital health, medical devices, and health IT. This guide focuses specifically on due diligence considerations at the Growth / Pre-IPO stage ($50M–$300M+ raise, $300M–$3B+).

Market Overview — HealthTech

TAM

$500B+ (digital health globally by 2030)

Growth

28% CAGR through 2030

Typical Investors

Health Catalyst Capital, General Catalyst, Rock Health, a16z Bio, strategic (Optum, Cigna, Cleveland Clinic)

Growth / Pre-IPO Stage at a Glance

Late-stage private growth round for companies with proven scale, approaching IPO readiness or major liquidity event.

Typical Raise: $50M–$300M+

Typical Valuation: $300M–$3B+

Team Expectations: Executive bench depth: two C-suite successors for each role. Independent board majority. IPO-grade legal and finance.

Traction Required: 500+ customers including recognizable enterprise brands. Global presence or credible international expansion.

Key Metrics for HealthTech Startups at Growth / Pre-IPO

These are the 5 metrics that institutional investors evaluate for HealthTech startups. DDR automatically extracts and benchmarks these from pitch deck data and OSINT sources.

Clinical Outcome Improvement

Must demonstrate statistically significant improvement vs. standard of care

The most defensible moat in healthtech

Payor Contract Rate

In-network with 3+ major payors is commercially viable

Without payor coverage, patient adoption is limited to self-pay

Provider Adoption Rate

30%+ of target providers actively using = strong PMF

Provider behavior change is notoriously difficult

Patient Engagement Rate

>40% monthly active for consumer health | >70% for condition management

Low engagement undermines outcome claims

Average Selling Price (ASP)

B2B SaaS to health systems: $50K–$500K/year

Enterprise health system deals have 9–18 month sales cycles

Red Flags in HealthTech Pitch Decks

DDR detects these 4 sector-specific red flags automatically when screening a HealthTech startup pitch deck. Each flag is severity-weighted based on impact to investment thesis.

CRITICAL

FDA clearance not secured for medical device or diagnostic claims

Any product that makes diagnostic or treatment claims requires FDA 510(k) clearance or De Novo authorization. Selling without clearance is illegal and investor-threatening.

CRITICAL

No HIPAA Business Associate Agreement (BAA) template

Any company handling Protected Health Information (PHI) must execute BAAs with covered entities. Absence signals regulatory immaturity.

HIGH

Clinical claims without peer-reviewed evidence

Healthtech companies that claim clinical superiority without published studies or rigorous data will face regulatory and payor scrutiny that stalls commercialization.

HIGH

No payor reimbursement pathway defined

Without a CPT code or payor coverage policy, the product's commercialization depends entirely on out-of-pocket or employer-sponsored payment.

Due Diligence Focus Areas: HealthTech

These are the priority investigation areas for HealthTech startups that experienced investors always verify before committing capital.

Verify FDA clearance status and any 510(k) submission history
Confirm HIPAA compliance framework: BAA templates, security officer, breach history
Review clinical evidence: study design, sample size, statistical significance
Assess payor coverage and reimbursement status
Interview reference customers (physicians, administrators, patients)

Key Questions to Ask the Founder

These founder interview questions surface the most common gaps and risks in HealthTech startup pitches.

What is your FDA regulatory strategy and what is the timeline to clearance?
How do you think about reimbursement — are you currently covered or seeking a CPT code?
Can you share your clinical outcomes data with methodology?
Who are the 3 health systems you're currently selling to and what does the sales cycle look like?

Comparable Companies & Exits: HealthTech

Omada Health

Seed to current: ~100x

IPO target, $1B+ valuation

Chronic condition digital health

Livongo / Teladoc

Seed to acquisition: ~500x

Acquired by Teladoc for $18.5B

Chronic disease management platform

Hims & Hers

Seed to IPO: ~50x

IPO via SPAC 2021, $1.6B

DTC digital health pharmacy

Regulatory & Compliance Risks

FDA 510(k) or PMA: medical device and diagnostic claims require pre-market review
HIPAA: PHI handling requires BAAs, security officer, breach notification protocol
Stark Law and Anti-Kickback Statute: referral and compensation arrangements in healthcare
State telehealth regulations: licensing requirements vary by state for clinical services

OSINT Signals to Check

DDR automatically checks these 4 signals from public sources when analyzing a HealthTech startup:

FDA 510(k) database: verify clearance status and device classification
PubMed: search for published clinical studies mentioning the company
ClinicalTrials.gov: check for registered studies
State medical board licensing records for any clinical staff

HealthTech Due Diligence — All Guides

AUTOMATE YOUR HEALTHTECH DUE DILIGENCE

Screen Any HealthTech Startup in 5 Minutes

Upload a pitch deck PDF and DDR automatically runs this full due diligence framework — 13 OSINT sources, founder verification, all sector-specific red flags, comparable company analysis, and INVEST/PASS verdict.

GET YOUR FREE SCAN →

View sample report · Pricing from $59

Due Diligence Guides by Sector

SaaS Fintech AI & ML EdTech CleanTech Marketplace E-Commerce Cybersecurity